-+ 0.00%
-+ 0.00%
-+ 0.00%

NEW TREMFYA® (GUSELKUMAB) STUDY SHOWS CONSISTENT PERIANAL FISTULA REMISSION ACROSS KEY CROHN'S DISEASE PATIENT SUBGROUPS

Reuters·10/12/2026 20:05:06

Please log in to view news